Dupilumab Gains Pediatric CSU Approval - Quiz - MDSpire

Dupilumab Gains Pediatric CSU Approval

Targets type 2 inflammation in a population with limited treatment options

  • By

  • Kathryn Wighton

  • April 24, 2026

  • 2 min

Share

Original Source(s)

Dupilumab Gains Pediatric CSU Approval

  • by Kathryn Wighton

  • April 24, 2026

Related Content

Digital technologies for non-invasive stress detection, monitoring, and mitigation in children and adolescents: a scoping review

Transcriptomic identification of IL-17/FOS-associated signaling in dartos fascia remodeling of pediatric concealed penis

Pyridoxine-dependent and other pyridoxine-responsive epilepsies—insights into phenotype overlapping and the long-term outcome in a cohort of 21 children